InvestorsHub Logo
Followers 2
Posts 134
Boards Moderated 0
Alias Born 03/02/2021

Re: None

Friday, 05/13/2022 12:17:32 PM

Friday, May 13, 2022 12:17:32 PM

Post# of 27660
New Quarterly Out

“In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fifth year of the ongoing HIV project (May 2022 to April 2023). The approval is pending as of May 13, 2022.

In May 2022, the Company entered into engagement agreements with two biotech consulting firms to source potential licensing, financing and/or acquisition opportunities for the Company under customary compensation terms.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News